A Prospective Randomized, Multicentre, Parallel Group, Placebo Controlled Trial of Dr SC DEB S Rheumalin in patients with acute and chronic pain in different parts of the human body

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2026
INTERVENTION: Intervention1: Dr SC DEB S Rheumalin homoeopathic medicine: Composition: Each 300Mg Contains 1. Bryonia Alba Q 0.003ml 2. Guaiacum Q 0.003ml 3. Macrotinum 2 X0.03 mg 4. Apocynum Cannabunum Q 0.003 ml 5. Gaultheria Procumbinum Q 0.003 ml 6. Cimicufuga Racemosa Q 0.006 ml 7. Kali Iodatum 1 X0.012 mgs 8. Saccharum Lactis QS Intervention2: Nil: Nil Control Intervention1: Placebo: Indistinguishable in appearance from verum Control Intervention2: Placebo: Nil CONDITION: Health Condition 1: ‐ Health Condition 2: M255‐ Pain in joint PRIMARY OUTCOME: Pain relief, Efficacy of the medicine and quality of lifeTimepoint: At Base line and every week, upto 1 month SECONDARY OUTCOME: Efficacy of the medicine in pain relief & quality of lifeTimepoint: At Base line & every week, upto 1 month INCLUSION CRITERIA: 1. Age 18‐70 years 2. Both male &female 3. Suffering Acute or Chronic pain 4. Intelligent enough to carefully record the facts, subjective & objective symptom s generated by the drug proving. 5. Able to be informed of the nature of the study and willing to give written informed consent.
Epistemonikos ID: a30bf09b62df74b9720b87478a45b5f5ea93c2bc
First added on: Jul 25, 2026